Mcl-1 Double Nickase Plasmid (h): sc-400079-NIC
- Target species: human
- 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
- Mcl-1 Double Nickase Plasmid (h) consists of a pair of plasmids each encoding a D10A mutated Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed to knockout gene expression with greater specificity than its CRISPR/Cas9 KO counterpart
- Paired gRNA sequences are offset by approximately 20 bp to allow for specific Cas9-mediated double nicking of the genomic DNA, which mimics a DSB
- One plasmid in the pair contains a puromycin-resistance gene for selection; the other plasmid in the pair contains a GFP marker to visually confirm transfection
- Mcl-1 Double Nickase Plasmid (h) and Mcl-1 Double Nickase Plasmid (h2) encode distinct paired gRNA designs targeting MCL1. One or both designs may be available
- Following transfection, gene knockout efficiency can be assayed by WB, IF or IHC using antibody: Mcl-1 Antibody (22): sc-12756
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Mcl-1 Double Nickase Plasmid (h) | sc-400079-NIC | 20 µg | $410.00 | |||
Mcl-1 Double Nickase Plasmid (h2) | sc-400079-NIC-2 | 20 µg | $410.00 |
MCL1 encodes the anti-apoptotic BCL-2 family protein Mcl-1, a key regulator of mitochondrial outer membrane permeabilization that restrains BAX/BAK-dependent apoptosis and supports cell survival. Mcl-1 integrates signals from stress and growth pathways, including PI3K–AKT, MAPK/ERK, and integrated stress responses, and is dynamically controlled by transcription, rapid proteasomal turnover, and phosphorylation. By shaping apoptotic threshold and mitochondrial homeostasis, MCL1 influences hematopoietic cell maintenance, immune cell activation, and responses to metabolic and genotoxic stress. Dysregulated MCL1 expression or stability is frequently associated with altered apoptosis in cancer biology and with cell survival phenotypes relevant to neurodegeneration and inflammatory settings.
Mcl-1 Double Nickase Plasmid (h) consists of a matched pair of plasmids engineered for high-specificity editing of the MCL1 locus in human cell lines. Each plasmid expresses a Cas9 D10A nickase and a distinct sgRNA targeting opposite DNA strands within MCL1. When directed to adjacent sites on opposite DNA strands, the two nickases generate offset single-strand nicks that together produce a staggered double-strand break, requiring coordinated on-target activity from both guides. The resulting DNA break is resolved by endogenous cellular repair pathways, most commonly through non-homologous end joining (NHEJ), leading to insertions or deletions that disrupt MCL1 function. By requiring dual sgRNA engagement at the target locus, the double nicking approach enhances editing specificity and provides a complementary CRISPR strategy for applications where additional control over targeting precision is desired.
To support efficient identification of edited cells, one plasmid encodes GFP for fluorescent visualization of transfected populations, while the companion plasmid carries a puromycin resistance gene for antibiotic selection. Together, these features support efficient enrichment of co-transfected populations and simplify the validation of MCL1-disrupted clones.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.